Laura Ley

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.

The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.

Journal: Journal of psychopharmacology (Oxford, England)

Published: December 26, 2025

Neuroplastic white matter changes in patients with major depression following lysergic acid diethylamide treatment.

Neuroplastic white matter changes in patients with major depression following lysergic acid diethylamide treatment.

Journal: Cell reports. Medicine

Published: July 25, 2025

Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants.

Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants.

Journal: Clinical pharmacokinetics

Published: June 22, 2025

Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings.

Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings.

Journal: International journal of methods in psychiatric research

Published: June 09, 2025

Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial.

Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial.

Journal: Med (New York, N.Y.)

Published: December 20, 2024

Safety pharmacology of acute mescaline administration in healthy participants.

Safety pharmacology of acute mescaline administration in healthy participants.

Journal: British journal of clinical pharmacology

Published: July 24, 2024

Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.

Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.

Journal: Psychopharmacology

Published: March 29, 2024

Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants.

Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants.

Journal: Translational psychiatry

Published: February 05, 2024

Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine.

Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine.

Journal: Molecular psychiatry

Published: January 16, 2024

Safety pharmacology of acute psilocybin administration in healthy participants.

Safety pharmacology of acute psilocybin administration in healthy participants.

Journal: Neuroscience applied

Published: December 18, 2023

The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.

The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.

Journal: Journal of psychopharmacology (Oxford, England)

Published: October 31, 2023

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: April 07, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026